A retrospective, real world study evaluating impact of Ruxolitinib on survival of patients with myelofibrosis
Latest Information Update: 08 Aug 2021
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Therapeutic Use
- 08 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association